R.L. Belote
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 6
- Cutaneous Melanoma Detection and Management 4
- Co-authors
- Sanford M. Simon (5 shared papers)Constantin N. Takacs (4 shared papers)Caroline E. Gleason (3 shared papers)Anne‐Katrin Emde (1 shared paper)Søren Germer (1 shared paper)Nicolas Robine (1 shared paper)Umesh Kumar Bhanot (1 shared paper)Robert L. Judson‐Torres (7 shared papers)
- Journals
- Nature (2 papers)Cell Reports (2 papers)Nature Cell Biology (1 paper)The Journal of Cell Biology (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesUnited KingdomMexico
In The Last Decade
R.L. Belote
15 papers receiving 857 citations
Peers
Comparison fields: 5 of 65
- Hepatology 262
- Cancer Research 133
- Cell Biology 71
- Oncology 112
- Molecular Biology 299
Countries citing papers authored by R.L. Belote
This map shows the geographic impact of R.L. Belote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.L. Belote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.L. Belote more than expected).
Fields of papers citing papers by R.L. Belote
This network shows the impact of papers produced by R.L. Belote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.L. Belote. The network helps show where R.L. Belote may publish in the future.
Co-authors
The 25 scholars most cited alongside R.L. Belote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 390 | |
| 2 | 2010 | 111 | |
| 3 | 2020 | 105 | |
| 4 | 2021 | 99 | |
| 5 | 2020 | 81 | |
| 6 | 2017 | 30 | |
| 7 | 2019 | 16 | |
| 8 | 2025 | 16 | |
| 9 | 2016 | 7 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 6 | |
| 12 | 2024 | 4 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2026 | 1 | |
| 16 | 2025 | 0 |
About R.L. Belote
R.L. Belote is a scholar working on Oncology, Hepatology, Cancer Research, Cell Biology and Molecular Biology, having authored 16 papers that have together received 875 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (4 papers), Digital Holography and Microscopy (2 papers), Cancer Genomics and Diagnostics (2 papers), melanin and skin pigmentation (2 papers), Lipid Membrane Structure and Behavior (1 paper), Cholesterol and Lipid Metabolism (1 paper) and Pluripotent Stem Cells Research (1 paper). The work is most often cited by research in Hepatology (262 citations), Cancer Research (133 citations), Cell Biology (71 citations), Oncology (112 citations) and Molecular Biology (299 citations). R.L. Belote has collaborated with scholars based in United States, United Kingdom and Mexico. Frequent co-authors include Sanford M. Simon, Constantin N. Takacs, Caroline E. Gleason, Anne‐Katrin Emde, Søren Germer, Nicolas Robine, Umesh Kumar Bhanot, Robert L. Judson‐Torres, Elana P. Simon and Rachel C. Chiaroni-Clarke. Their work appears in journals such as Nature, Cell Reports, Nature Cell Biology, The Journal of Cell Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.